Unique Complications of MIS-C and Its Treatment: Encephalopathy in a Child with MIS-C Who Developed Life-Threatening Gastrointestinal Hemorrhage.


Journal

Case reports in critical care
ISSN: 2090-6420
Titre abrégé: Case Rep Crit Care
Pays: United States
ID NLM: 101598416

Informations de publication

Date de publication:
2022
Historique:
received: 13 01 2022
revised: 09 08 2022
accepted: 13 10 2022
entrez: 1 11 2022
pubmed: 2 11 2022
medline: 2 11 2022
Statut: epublish

Résumé

In this case report, we describe a previously healthy eleven-year-old male diagnosed with multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019. The patient presented with shock and neurologic symptoms including altered mental status and dysarthria. Brain magnetic resonance imaging, obtained to rule out thromboembolic injury, demonstrated cytotoxic edema of the corpus callosum, an imaging finding similar in nature to several previous reports of MRI abnormalities in children with MIS-C. Following administration of intravenous immunoglobulin and pulse-dose steroids, the patient convalesced and was discharged home. Medications prescribed upon discharge included a steroid taper, daily aspirin, and proton pump inhibitor. Four days later, he was readmitted with shock and life-threatening gastrointestinal (GI) hemorrhage. After extensive evaluation of potential bleeding sources, angiography revealed active bleeding from two arterial vessels supplying the duodenum. The patient demonstrated no further signs of bleeding following successful coil embolization of the two vessels. We hypothesize that the vasculitic nature of MIS-C combined with anti-inflammatory and antithrombotic therapy placed him at risk of GI hemorrhage. This case highlights unique radiologic features of MIS-C as well as potential complications of treatment.

Identifiants

pubmed: 36317092
doi: 10.1155/2022/7244434
pmc: PMC9617717
doi:

Types de publication

Case Reports

Langues

eng

Pagination

7244434

Informations de copyright

Copyright © 2022 Luke Burton et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Neurol Sci. 2020 Nov 15;418:117096
pubmed: 32823135
J Neurol Sci. 2012 Apr 15;315(1-2):167-9
pubmed: 22129937
JAMA Neurol. 2020 Nov 1;77(11):1440-1445
pubmed: 32609336
Radiographics. 2017 Mar-Apr;37(2):562-576
pubmed: 28165876
EClinicalMedicine. 2020 Sep;26:100527
pubmed: 32923992
JAMA Neurol. 2021 May 1;78(5):536-547
pubmed: 33666649
J Clin Invest. 2020 Nov 2;130(11):5967-5975
pubmed: 32730233
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
Arthritis Rheumatol. 2020 Nov;72(11):1791-1805
pubmed: 32705809
Children (Basel). 2020 Sep 10;7(9):
pubmed: 32927628
Indian J Pediatr. 2021 Jun;88(6):607
pubmed: 33745112
Neurosci Lett. 2021 Jan 19;743:135567
pubmed: 33352286
AJNR Am J Neuroradiol. 2020 Oct;41(10):1905-1907
pubmed: 32819904
AJNR Am J Neuroradiol. 2020 Nov;41(11):2017-2019
pubmed: 32819898
Lancet Child Adolesc Health. 2021 Mar;5(3):167-177
pubmed: 33338439
Korean J Radiol. 2017 Jul-Aug;18(4):710-721
pubmed: 28670166
Gastroenterology. 2020 Oct;159(4):1571-1574.e2
pubmed: 32505742

Auteurs

Luke Burton (L)

University of Alabama at Birmingham, Birmingham, AL, USA.

Ananya Manchikalapati (A)

University of Alabama at Birmingham, Birmingham, AL, USA.

Chrystal Rutledge (C)

University of Alabama at Birmingham, Birmingham, AL, USA.

Jeremy M Loberger (JM)

University of Alabama at Birmingham, Birmingham, AL, USA.

Nicholas Rockwell (N)

University of Alabama at Birmingham, Birmingham, AL, USA.

Joshua Cooper (J)

University of Alabama at Birmingham, Birmingham, AL, USA.

Maggie Lawrence (M)

Children's of Alabama, Birmingham, Alabama, USA.

William C Sasser (WC)

University of Alabama at Birmingham, Birmingham, AL, USA.

Classifications MeSH